Dan Godley, 31, says ordinarily he would be prescribed around 10 bottles of Creon a month, but the most he has had from his pharmacy in the last five months is three bottles.

A pancreatic cancer patient says he has been “left in the lurch” by a shortage of medication he depends on to digest food.

Dan Godley, 31, was diagnosed with pancreatic cancer at the age of 28 and has needed enzyme replacement therapy drug Creon ever since.

But a global supply shortage means Mr Godley is among 60,000 patients who could be experiencing difficulties accessing the medication.

Creon supports the breaking down of fat and help patients get the nutrients needed from food.

“Depending on how much fat is in the meal, will kind of change how much of the medication you need to take,” Mr Godley explains.

Putting it in language everyone can understand, he says: “For something like pizza, that’s a very high-fat meal, I would probably take 15 of the tablets in one meal… probably 30 on average each day.”

Mr Godley says ordinarily he would be prescribed around 10 bottles a month, but “the most I have had from my pharmacy in the last five months is three bottles”

He has help from family members who travel almost 200 miles from Cheshire to London, where, for now, Creon can be sourced.

But he worries this process is complicated and unsustainable.